Summary
Machine-generated summaryThis public tender covers the supply of pharmaceutical products, specifically the medicines Aflibercept and Faricimab. These are active substances used in ophthalmic treatments, notably for retinal conditions such as wet age-related macular degeneration and other retinal vascular diseases. The notice classifies the procurement under CPV code 33600000-6 for pharmaceutical products. The summary of the notice is limited to the title information provided, which names the product categories and the two active substances to be procured. Potential suppliers of these medicines may follow the tender procedure as published.
Official source
Source: ProZorro - Public e-procurement of Ukraine
Always verify details on the official notice.
Last verified against ProZorro - Public e-procurement of Ukraine 2 days ago
More from this buyer
Full buyer profile9 open tenders right now
- CPV 33730000-6 - Ophthalmological products and corrective lenses (Intraocular lens with iridocapsular fixation; intraoperative material for replacing aqueous humour/vitreous fluid of the eye) 4 days left
- CPV 45450000-6 - Other completion construction works - Current repair of premises in the urology department, Cherkasy Regional Hospital 6 days left
- CPV 33690000-3 Various medicines (Reagents for clinical diagnostic laboratory for the Cobas c 311 analyser) 6 days left
Recent awards
- CPV 72250000-2: Services related to systems and support (Software support and maintenance services for the medical information system 'MedInfoService')
- CPV 021:2015:66510000-8 - Insurance services (compulsory insurance of civil liability of owners of land vehicles)
- CPV 021:2015: 09130000-9 - Petroleum and distillates (A-95 petrol, diesel fuel)
Similar tenders
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €10,072,553
- Buyer track record on Aperlena
- 287 notices tracked · 229 awarded
Never miss a tender like this
1,964 new notices in Medical equipment & pharmaceuticals in Ukraine in the last 7 days. Get an email when new ones appear. Free.
Set up my alert